Envy Medical and Libbs Farmaceutica signed a deal to manufacture, market and sell Envy’s proprietary Lumixyl Brightening Creme throughout the country of Brazil.
This is a significant milestone for Envy Medical’s professional skin care products, as it not only represents a significant agreement with Libbs, a leader in the sales and supply of pharmaceutical products, it also represents a solid entry into the largest single skincare market outside of the US, it contends.
“The population of Brazil possesses a strong and growing demand for an effective alternative to hydroquinone, and particularly one without the side effects associated with prescription hydroquinone,” said Curtis A. Cluff, CEO of Envy Medical, Inc., “I am particularly excited to work with Libbs, as they are a major force and a partner of unparalleled capability, ethics and integrity.
Products that can effectively address hyperpigmentation and photo-damage and are in demand in the country, which not only has a large Latin population more genetically disposed to hyperpigmentation issues, but also the largest population of Japanese decent outside of Japan. For women (and increasingly men) of either heritage, a clear, more even skin tone is culturally important in building a stronger sense of confidence and self-esteem.
“We are pleased to bring this safe and effective skincare technology for brighter and more even skin-tone to the women and men of Brazil.” Said Alcebíades de Mendonça Athayde Junior, CEO of Libbs, “The Lumixyl Brightening Creme has tested extremely well with our initial focus groups and dermatologists, both in terms of its efficacy and unique aesthetic qualities.”
The agreement was also facilitated by Aime Medical, Inc., a Clearwater Florida based company that acted as Envy’s international agent in identifying Libbs as the premier partner for Lumixyl in Brazil, and thereafter assisting with product launch and training activities.
Under the agreement, LIibbs and Envy have collaborated in developing manufacturing capabilities for Envy products in Brazil, with Libbs leading the way in executing a tailored branding and sales strategy. The Lumixyl Brightening Creme will arrive at the Brazilian market at a suggested retail price of R$ 140.00 for a 30ml bottle. Libbs has already made the product available in over 3,000 retail drugstores and specialty pharmacies throughout Brazil with future distribution expansion plans.